Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FBXO34 antisense RNA 1 (FBXO34-AS1) is a long non-coding RNA (lncRNA) classified as an antisense RNA; it is transcribed from the opposite strand of the FBXO34 protein-coding gene locus and is not known to be translated into protein[1][2][3][6][7][9]. As with other lncRNAs in the antisense classification, its likely function involves regulation of gene expression of the overlapping sense gene, in this case, FBXO34. There are no reported roles as a druggable target, biomarker, or established disease association based on current available data, and no information supports direct drug interactions or mechanisms of action.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FBXO34 antisense RNA 1 (FBXO34-AS1).